| 201076-100MG |
|
NA |
(11aR)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C37H27F12O4P |
|
|
|
| 201076-25MG |
|
NA |
(11aR)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C37H27F12O4P |
|
|
|
| 201075-1G |
|
NA |
(11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C33H31O4P |
|
|
|
| 201075-100MG |
|
NA |
(11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C33H31O4P |
|
|
|
| 201075-25MG |
|
NA |
(11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C33H31O4P |
|
|
|
| 201074-1G |
|
NA |
(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C33H31O4P |
|
|
|
| 201074-100MG |
|
NA |
(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C33H31O4P |
|
|
|
| 201074-25MG |
|
NA |
(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C33H31O4P |
|
|
|
| 201073-1G |
|
NA |
(11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C21H23O4P |
|
|
|
| 201073-100MG |
|
NA |
(11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C21H23O4P |
|
|
|
| 201073-25MG |
|
NA |
(11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C21H23O4P |
|
|
|
| 201072-1G |
|
NA |
(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C21H23O4P |
|
|
|
| 201072-100MG |
|
NA |
(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C21H23O4P |
|
|
|
| 201072-25MG |
|
NA |
(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C21H23O4P |
|
|
|
| 201145-500MG |
|
NA |
3-(tert-Butyl)-4-(4',6'-dime thoxy-[1,1':3',1''-terphenyl]-5'-yl)-2,3-dihydrobenzo[d ][1,3]oxaphosphole
≥95%,99%e.e.
|
500MG |
C31H31O3P |
|
|
|
| 201145-100MG |
|
NA |
3-(tert-Butyl)-4-(4',6'-dime thoxy-[1,1':3',1''-terphenyl]-5'-yl)-2,3-dihydrobenzo[d ][1,3]oxaphosphole
≥95%,99%e.e.
|
100MG |
C31H31O3P |
|
|
|
| 201144-500MG |
|
NA |
2-[(2S,3S)-4-(9-Anthracenyl)-3-(1,1-dimethylethyl)-2,3-dihydro-1,3-benzoxaphosphol-2-yl]-pyridine
≥95%,99%e.e.
|
500MG |
C30H26NOP |
|
|
|
| 201144-100MG |
|
NA |
2-[(2S,3S)-4-(9-Anthracenyl)-3-(1,1-dimethylethyl)-2,3-dihydro-1,3-benzoxaphosphol-2-yl]-pyridine
≥95%,99%e.e.
|
100MG |
C30H26NOP |
|
|
|
| 201143-500MG |
|
1542796-14-4 |
2-[(2R,3R)-4-(9-Anthracenyl)-3-(1,1-dimethylethyl)-2,3-dihydro-1,3-benzoxaphosphol-2-yl]-pyridine
≥95%,99%e.e.
|
500MG |
C30H26NOP |
|
|
|
| 201143-100MG |
|
1542796-14-4 |
2-[(2R,3R)-4-(9-Anthracenyl)-3-(1,1-dimethylethyl)-2,3-dihydro-1,3-benzoxaphosphol-2-yl]-pyridine
≥95%,99%e.e.
|
100MG |
C30H26NOP |
|
|
|
